Hot Pursuit     02-Nov-15
GlaxoSmithKline Pharma slips after weak Q2 outcome
GlaxoSmithKline Pharmaceuticals fell 1.84% to Rs 3,234.10 at 9:54 IST on BSE after net profit fell 25.35% to Rs 96.05 crore on 6.52% decline in total income to Rs 731.43 crore in Q2 September 2015 over Q2 September 2014.

The result was announced on Saturday, 31 October 2015.

Meanwhile, the BSE Sensex was down 133.86 points, or 0.50%, to 26,522.97.

On BSE, so far 737 shares were traded in the counter, compared with an average volume of 2,763 shares in the past one quarter.

The stock hit a high of Rs 3,266.50 and a low of Rs 3,222.20 so far during the day. The stock hit a record high of Rs 3,825 on 5 August 2015. The stock hit a 52-week low of Rs 2,681 on 3 November 2014.

The stock had underperformed the market over the past one month till 30 October 2015, falling 1.34% compared with 1.92% rise in the Sensex. The scrip had also underperformed the market in past one quarter, sliding 6.52% as against Sensex's 3.78% decline.

The large-cap company has an equity capital of Rs 84.70 crore. Face value per share is Rs 10.

GlaxoSmithkline Pharmaceuticals is engaged in the business of manufacturing, distributing and trading in pharmaceuticals.

Previous News
  Glaxosmithkline Pharmaceuticals fixes record date for final dividend
 ( Market Beat - Reports 19-May-21   09:16 )
  GSK Pharma Q4 PAT drops 89% YoY; declares dividend of Rs 32/share
 ( Hot Pursuit - 18-May-23   09:43 )
  Glaxosmithkline Pharmaceuticals consolidated net profit declines 89.05% in the March 2023 quarter
 ( Results - Announcements 17-May-23   17:35 )
  GSK Pharma hits 3-month low after Q3 net loss of Rs 661.16 cr
 ( Hot Pursuit - 04-Feb-20   09:40 )
  Glaxosmithkline Pharmaceuticals standalone net profit rises 16.56% in the March 2019 quarter
 ( Results - Announcements 20-May-19   16:03 )
  Board of Glaxosmithkline Pharma recommends final dividend
 ( Corporate News - 20-May-17   15:52 )
  Glaxo SmithKline Pharmaceuticals
 ( Results - Analysis 17-Feb-12   12:51 )
  GSK Pharma rises after Q2 PAT jumps 76% YoY
 ( Hot Pursuit - 01-Nov-21   09:14 )
  Board of Glaxosmithkline Pharma recommends final dividend
 ( Corporate News - 18-May-15   14:15 )
  Board of GlaxoSmithKline Pharmaceuticals recommends Final Dividend
 ( Corporate News - 19-May-21   10:31 )
  Glaxosmithkline Pharmaceuticals consolidated net profit declines 72.22% in the December 2023 quarter
 ( Results - Announcements 13-Feb-24   07:36 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top